VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway

[1]  B. Rovin,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[2]  Minoru Kanehisa,et al.  KEGG: integrating viruses and cellular organisms , 2020, Nucleic Acids Res..

[3]  S. Sethi.  New 'Antigens' in Membranous Nephropathy. , 2020, Journal of the American Society of Nephrology : JASN.

[4]  L. Kiemeney,et al.  The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis , 2020, Nature Communications.

[5]  Yasufumi Sato,et al.  Targeting angiogenesis and lymphangiogenesis in kidney disease , 2020, Nature Reviews Nephrology.

[6]  H. Debiec,et al.  Molecular Pathogenesis of Membranous Nephropathy. , 2020, Annual review of pathology.

[7]  P. Burbelo,et al.  Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy. , 2019, Journal of the American Society of Nephrology : JASN.

[8]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[9]  Ayumi Matsumoto,et al.  VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  S. Mallipattu,et al.  Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities. , 2019, Journal of the American Society of Nephrology : JASN.

[11]  Yan G Zhao,et al.  Autophagosome maturation: An epic journey from the ER to lysosomes , 2018, The Journal of cell biology.

[12]  L. Quintana,et al.  Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy , 2018, Clinical kidney journal.

[13]  Yu Zhang,et al.  Modified Huangqi Chifeng decoction inhibits excessive autophagy to protect against Doxorubicin-induced nephrotic syndrome in rats via the PI3K/mTOR signaling pathway , 2018, Experimental and therapeutic medicine.

[14]  Y. Maeshima,et al.  Antiangiogenic Therapy for Diabetic Nephropathy , 2017, BioMed research international.

[15]  S. Luo,et al.  Accumulation of autophagosomes confers cytotoxicity , 2017, The Journal of Biological Chemistry.

[16]  Ahmad M. Al-Taee,et al.  Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration , 2017, Journal of nephropathology.

[17]  Peter Boor,et al.  Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. , 2017, Kidney international.

[18]  C. V. Vander Kooi,et al.  Neuropilin Functions as an Essential Cell Surface Receptor* , 2015, The Journal of Biological Chemistry.

[19]  T. Coffman,et al.  Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney. , 2015, Journal of the American Society of Nephrology : JASN.

[20]  S. Quaggin,et al.  Crosstalk in glomerular injury and repair , 2015, Current opinion in nephrology and hypertension.

[21]  D. Harris,et al.  Heymann Nephritis in Lewis Rats , 2015, Current protocols in immunology.

[22]  Chung-Yen Lin,et al.  cytoHubba: identifying hub objects and sub-networks from complex interactome , 2014, BMC Systems Biology.

[23]  T. Takano,et al.  Complement-mediated cellular injury. , 2013, Seminars in nephrology.

[24]  Tetsuhiro Tanaka,et al.  Angiogenesis and hypoxia in the kidney , 2013, Nature Reviews Nephrology.

[25]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[26]  T. Curran,et al.  Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. , 2012, The Journal of clinical investigation.

[27]  克治 桑門.  海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[28]  B. Croker,et al.  The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy , 2008, Laboratory Investigation.

[29]  D. Nochy,et al.  VEGF inhibition and renal thrombotic microangiopathy. , 2008, The New England journal of medicine.

[30]  David Bryant,et al.  DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..

[31]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Flyvbjerg,et al.  The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. , 2004, Kidney international.

[33]  O. Bairey,et al.  All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. , 2004, Leukemia research.

[34]  W. Couser,et al.  DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. , 2003, The Journal of clinical investigation.

[35]  J. Haigh,et al.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.

[36]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[37]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..